-
1
-
-
26844560991
-
Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukemia
-
accepted
-
Ahlke E, Nowak-Göttl U, Schulze-Westhoff P, Werber G, Borste H, Wurthwein G, Jürgens H, Boos J 1996 Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukemia. Br J Hematol accepted
-
(1996)
Br J Hematol
-
-
Ahlke, E.1
Nowak-Göttl, U.2
Schulze-Westhoff, P.3
Werber, G.4
Borste, H.5
Wurthwein, G.6
Jürgens, H.7
Boos, J.8
-
2
-
-
0027197614
-
Comparative pharmacokinetic studies of three asparaginase preparations
-
Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen KT 1993 Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 11: 1780-1786
-
(1993)
J Clin Oncol
, vol.11
, pp. 1780-1786
-
-
Asselin, B.L.1
Whitin, J.C.2
Coppola, D.J.3
Rupp, I.P.4
Sallan, S.E.5
Cohen, K.T.6
-
3
-
-
0030218821
-
Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations
-
Boos J, Werber G, Ahlke E, Schulze-Westhoff P, Nowak-Göttl U, Verspohl E, Ritter J, Jürgens H 1996 Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer32A: 1540-1544
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 1540-1544
-
-
Boos, J.1
Werber, G.2
Ahlke, E.3
Schulze-Westhoff, P.4
Nowak-Göttl, U.5
Verspohl, E.6
Ritter, J.7
Jürgens, H.8
-
4
-
-
0019737171
-
L-asparaginase: Discovery and development as a tumor-inhibitory agent
-
Broome JD 1981 L-asparaginase: discovery and development as a tumor-inhibitory agent. Cancer Treat Rep 65 (Suppl 4): 111-114
-
(1981)
Cancer Treat Rep
, vol.65
, Issue.4 SUPPL.
, pp. 111-114
-
-
Broome, J.D.1
-
5
-
-
0025642988
-
Nonrandomized study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukemia
-
Eden OB, Shaw MP, Lilleyman JS, Richards S 1990 Nonrandomized study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukemia. Med Pediatr Oncol 18: 497-502
-
(1990)
Med Pediatr Oncol
, vol.18
, pp. 497-502
-
-
Eden, O.B.1
Shaw, M.P.2
Lilleyman, J.S.3
Richards, S.4
-
6
-
-
0028069252
-
Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: Risk of thrombotic complications in L-asparaginase-induced antithrombin III deficiency
-
Mitchell L, Hoogendoorn H, Giles AR, Vegh P, Andrew M 1994 Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L-asparaginase-induced antithrombin III deficiency. Blood 83: 386-391
-
(1994)
Blood
, vol.83
, pp. 386-391
-
-
Mitchell, L.1
Hoogendoorn, H.2
Giles, A.R.3
Vegh, P.4
Andrew, M.5
-
7
-
-
0019746919
-
L-asparaginase as a single agent in acute lymphocytic leukemia: Survey of studies form Childrens Canca Study Group
-
Nesbit ME, Ertel I, Hammond GD 1981 L-asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Canca Study Group. Canca Treat Rep 65 (Suppl 4): 101-107
-
(1981)
Canca Treat Rep
, vol.65
, Issue.4 SUPPL.
, pp. 101-107
-
-
Nesbit, M.E.1
Ertel, I.2
Hammond, G.D.3
-
8
-
-
0028076918
-
Enhanced thrombin generation, P von Willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated children
-
Nowak-Göttl U, Wolff JEA, Kuhn N, Boos J, Kehrel B, Lilienweiss V, Schwabe D, Jürgens H 1994 Enhanced thrombin generation, P von Willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: predictive for venous thrombosis in asparaginase-treated children. Fibronolysis 8 (Suppl 2): 63-65
-
(1994)
Fibronolysis
, vol.8
, Issue.2 SUPPL.
, pp. 63-65
-
-
Nowak-Göttl, U.1
Wolff, J.E.A.2
Kuhn, N.3
Boos, J.4
Kehrel, B.5
Lilienweiss, V.6
Schwabe, D.7
Jürgens, H.8
-
9
-
-
0030326241
-
Influence of two different E. coli asparaginase preparations on fibrinolytic proteins in childhood ALL
-
Nowak-Göttl U, Werber G, Ziemann D, Ahlke E, Boos J 1996a Influence of two different E. coli asparaginase preparations on fibrinolytic proteins in childhood ALL. Haematologica 81: 127-131
-
(1996)
Haematologica
, vol.81
, pp. 127-131
-
-
Nowak-Göttl, U.1
Werber, G.2
Ziemann, D.3
Ahlke, E.4
Boos, J.5
-
10
-
-
0029797696
-
Changes in coagulation and fibrinolysis in childhood ALL: A two-step dose reduction of one E. coli asparaginase preparation
-
Nowak-Götll U, Ahlke E, Schulze-Westhoff P, Boos J 1996b Changes in coagulation and fibrinolysis in childhood ALL: A two-step dose reduction of one E. coli asparaginase preparation. Br J Haematol 95: 123-126
-
(1996)
Br J Haematol
, vol.95
, pp. 123-126
-
-
Nowak-Götll, U.1
Ahlke, E.2
Schulze-Westhoff, P.3
Boos, J.4
-
11
-
-
0005731933
-
The importance of L-Asparaginase(A'Ase) in the treatment of Acute Lymphoblastic Leukemia (ALL) in children: Results of the EORTC 58881 randomized phase III trial showing greater efficacy of Escheria Coli (E.coli) as compared to Erwinia(Erw) A'Ase
-
Otten J, Suciu S, Benoit Y, Robert A, Thyss A, Plouvier E, Ferster A, Mechinaud F, Mazingue F, Brock P, Vilmer E, Solbu G, Waterkeyn C, Philippe N 1996 The importance of L-Asparaginase(A'Ase) in the treatment of Acute Lymphoblastic Leukemia (ALL) in children: results of the EORTC 58881 randomized phase III trial showing greater efficacy of Escheria Coli (E.coli) as compared to Erwinia(Erw) A'Ase. Blood 88 (Suppl1):669A
-
(1996)
Blood
, vol.88
, Issue.1 SUPPL.
-
-
Otten, J.1
Suciu, S.2
Benoit, Y.3
Robert, A.4
Thyss, A.5
Plouvier, E.6
Ferster, A.7
Mechinaud, F.8
Mazingue, F.9
Brock, P.10
Vilmer, E.11
Solbu, G.12
Waterkeyn, C.13
Philippe, N.14
-
12
-
-
0019778519
-
L-asparaginase pharmacokinetics and asparagine levels in cerebro-spinal fluid of rhesus monkeys and humans
-
Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG 1981 L-asparaginase pharmacokinetics and asparagine levels in cerebro-spinal fluid of rhesus monkeys and humans. Cancer Res 41: 4554-4558
-
(1981)
Cancer Res
, vol.41
, pp. 4554-4558
-
-
Riccardi, R.1
Holcenberg, J.S.2
Glaubiger, D.L.3
Wood, J.H.4
Poplack, D.G.5
-
13
-
-
0026887274
-
Gerinnungsveränderungen bei Behandlung mit den Protokollen ALL-BFM-90 und NEW BFM-90
-
Sutor AH, Niemeyer C, Sauter S, Witt I, Kaufmehl K, Rombach A, Brandis M, Riehm H 1992 Gerinnungsveränderungen bei Behandlung mit den Protokollen ALL-BFM-90 und NEW BFM-90. Klin Pädiatr 204: 264-273
-
(1992)
Klin Pädiatr
, vol.204
, pp. 264-273
-
-
Sutor, A.H.1
Niemeyer, C.2
Sauter, S.3
Witt, I.4
Kaufmehl, K.5
Rombach, A.6
Brandis, M.7
Riehm, H.8
-
14
-
-
0002859852
-
Asparaginase activities in vitro are highly sensitive to different buffer conditions
-
in press
-
Verber G, Ahlke E, Nowak-Götll U, Jürgens H, Verspohl KJ, Boos J 1996 Asparaginase activities in vitro are highly sensitive to different buffer conditions. Haematol Blood Transfus 38: in press
-
(1996)
Haematol Blood Transfus
, vol.38
-
-
Verber, G.1
Ahlke, E.2
Nowak-Götll, U.3
Jürgens, H.4
Verspohl, K.J.5
Boos, J.6
|